Oramed Pharmaceuticals Stock Analysis

Oramed Stock Analysis Notes

About 14.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oramed Pharmaceuticals had not issued any dividends in recent years. The entity had 1:12 split on the 23rd of January 2013. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York. Oramed Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Oramed Pharmaceuticals contact Nadav Esq at 844 967 2633 or learn more at https://www.oramed.com.

Oramed Pharmaceuticals Investment Alerts

Oramed Pharmaceuticals Upcoming and Recent Events

Oramed Largest EPS Surprises

View All Earnings Estimates

Oramed Stock Institutional Investors

Note, although Oramed Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Oramed Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 91.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oramed Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Oramed Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Oramed Profitablity

The company has Profit Margin (PM) of 4.12 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of (11.77) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $11.77.

Management Efficiency

Oramed Pharmaceuticals has return on total asset (ROA) of (0.0516) % which means that it has lost $0.0516 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0324 %, meaning that it created $0.0324 on every $100 dollars invested by stockholders. Oramed Pharmaceuticals' management efficiency ratios could be used to measure how well Oramed Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/23/2024, Return On Tangible Assets is likely to drop to -0.22. In addition to that, Return On Capital Employed is likely to drop to -0.25. At this time, Oramed Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 04/23/2024, Liabilities And Stockholders Equity is likely to grow to about 195.2 M, while Non Current Liabilities Total is likely to drop slightly above 4 M.

Technical Drivers

As of the 23rd of April, Oramed Pharmaceuticals holds the Risk Adjusted Performance of 0.0305, coefficient of variation of 2801.47, and Semi Deviation of 3.89. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oramed Pharmaceuticals, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for nineteen technical drivers for Oramed Pharmaceuticals, which can be compared to its competitors. Please check Oramed Pharmaceuticals standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Oramed Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 2.33 per share. Please also confirm Oramed Pharmaceuticals total risk alpha, which is currently at (0.42) to check out the company can sustain itself at a future point.

Oramed Pharmaceuticals Price Movement Analysis

Oramed Pharmaceuticals Insider Trading Activities

Oramed Pharmaceuticals Predictive Daily Indicators

Oramed Pharmaceuticals Corporate Filings

Oramed Pharmaceuticals Forecast Models

Oramed Pharmaceuticals' time-series forecasting models are one of many Oramed Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oramed Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Oramed Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oramed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oramed Pharmaceuticals. By using and applying Oramed Stock analysis, traders can create a robust methodology for identifying Oramed entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Oramed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Oramed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Oramed Pharmaceuticals stock analysis indicators help investors evaluate how Oramed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Oramed Pharmaceuticals shares will generate the highest return on investment. By understating and applying Oramed Pharmaceuticals stock analysis, traders can identify Oramed Pharmaceuticals position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oramed Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Oramed Stock, please use our How to Invest in Oramed Pharmaceuticals guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Oramed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oramed Pharmaceuticals. If investors know Oramed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oramed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Oramed Pharmaceuticals is measured differently than its book value, which is the value of Oramed that is recorded on the company's balance sheet. Investors also form their own opinion of Oramed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oramed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oramed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oramed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Oramed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oramed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.